{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T02:09:54Z","timestamp":1793844594305,"version":"4.6.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2009]]},"DOI":"10.1080\/14653240902849788","type":"journal-article","created":{"date-parts":[[2009,6,15]],"date-time":"2009-06-15T08:49:44Z","timestamp":1245055784000},"page":"464-471","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":141,"title":["Granulocyte colony-stimulating factor (G-CSF) administration in individuals with sickle cell disease: time for a moratorium?"],"prefix":"10.1016","volume":"11","author":[{"given":"Courtney D.","family":"Fitzhugh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew M.","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles D.","family":"Bolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Saenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Tisdale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9107","key":"10.1080\/14653240902849788_bib0005","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0140-6736(05)60614-9","article-title":"Granulocytosis causing sickle-cell crisis","volume":"351","author":"Abboud","year":"1998","journal-title":"Lancet"},{"issue":"10","key":"10.1080\/14653240902849788_bib0010","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1182\/blood.V97.10.3313","article-title":"Fatal sickle cell crisis after granulocyte colony-stimulating factor administration","volume":"97","author":"Adler","year":"2001","journal-title":"Blood"},{"issue":"12","key":"10.1080\/14653240902849788_bib0015","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1182\/blood.V97.12.3998","article-title":"Granulocyte colony-stimulating factor-induced sickle cell crisis and multiorgan dysfunction in a patient with compound heterozygous sickle cell\/beta + thalassemia","volume":"97","author":"Grigg","year":"2001","journal-title":"Blood"},{"issue":"11","key":"10.1080\/14653240902849788_bib0020","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/sj.bmt.1705376","article-title":"Successful mobilization and transplantation of filgrastim mobilized hematopoietic stem cells in sickle cell-hemoglobin C disease","volume":"37","author":"Kamble","year":"2006","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1080\/14653240902849788_bib0025","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.bbmt.2008.03.001","article-title":"Granulocyte colony-stimulating factor-based stem cell mobilization in patients with sickle cell disease","volume":"14","author":"Rosenbaum","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"10.1080\/14653240902849788_bib0030","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1016\/j.transproceed.2003.10.085","article-title":"Autologous bone marrow transplant in a patient with sickle cell disease and diffuse large B-cell lymphoma","volume":"35","author":"Onitilo","year":"2003","journal-title":"Transplant Proc"},{"issue":"9","key":"10.1080\/14653240902849788_bib0035","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1111\/j.1537-2995.2008.01777.x","article-title":"Mobilization, collection, and transplantation of peripheral blood hematopoietic progenitor cells in a patient with multiple myeloma and hemoglobin SC disease","volume":"48","author":"Tormey","year":"2008","journal-title":"Transfusion"},{"issue":"2","key":"10.1080\/14653240902849788_bib0040","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2310\/6650.2007.06029","article-title":"Cytokine concentrations in bone marrow of stable sickle cell anemia patients","volume":"55","author":"Dallalio","year":"2007","journal-title":"J Invest Med"},{"issue":"2","key":"10.1080\/14653240902849788_bib0045","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1203\/pdr.0b013e31802d7754","article-title":"Energy expenditure, inflammation, and oxidative stress in steady-state adolescents with sickle cell anemia","volume":"61","author":"Akohoue","year":"2007","journal-title":"Pediatric Res"},{"issue":"7","key":"10.1080\/14653240902849788_bib0050","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1161\/01.ATV.0000220374.00602.a2","article-title":"Biologically active CD40 ligand is elevated in sickle cell anemia: potential role for platelet-mediated inflammation","volume":"26","author":"Lee","year":"2006","journal-title":"Arteriosclerosis, thrombosis, and vascular biology"},{"issue":"23","key":"10.1080\/14653240902849788_bib0055","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease. Life expectancy and risk factors for early death","volume":"330","author":"Platt","year":"1994","journal-title":"New Engl J Med"},{"issue":"2","key":"10.1080\/14653240902849788_bib0060","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1056\/NEJM200001133420203","article-title":"Prediction of adverse outcomes in children with sickle cell disease","volume":"342","author":"Miller","year":"2000","journal-title":"New Engl J Med"},{"issue":"2","key":"10.1080\/14653240902849788_bib0065","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1182\/blood-2007-07-100719","article-title":"Prediction of adverse outcomes in children with sickle cell anemia: a study of the Dallas Newborn Cohort","volume":"111","author":"Quinn","year":"2008","journal-title":"Blood"},{"issue":"20","key":"10.1080\/14653240902849788_bib0070","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJM199505183322001","article-title":"Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia","volume":"332","author":"Charache","year":"1995","journal-title":"New Engl J Med"},{"issue":"1","key":"10.1080\/14653240902849788_bib0075","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000040964","article-title":"Levels of endothelial, neutrophil and platelet-specific factors in sickle cell anemia patients during hydroxyurea therapy","volume":"102","author":"Saleh","year":"1999","journal-title":"Acta Haematol"},{"issue":"5","key":"10.1080\/14653240902849788_bib0080","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/00043426-200106000-00014","article-title":"Hydroxyurea therapy for pediatric patients with hemoglobin SC disease","volume":"23","author":"Miller","year":"2001","journal-title":"J Pediatr Hematol Oncol"},{"issue":"2","key":"10.1080\/14653240902849788_bib0085","first-page":"482","article-title":"Elevated serum and bronchoalveolar lavage fluid levels of interleukin 8 and granulocyte colony-stimulating factor associated with the acute chest syndrome in patients with sickle cell disease","volume":"111","author":"Abboud","year":"2000","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1080\/14653240902849788_bib0090","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1365-2141.2007.06748.x","article-title":"Inhibition of caspase-dependent spontaneous apoptosis via a cAMP-protein kinase A dependent pathway in neutrophils from sickle cell disease patients","volume":"139","author":"Conran","year":"2007","journal-title":"Br J Haematol"},{"issue":"10","key":"10.1080\/14653240902849788_bib0095","doi-asserted-by":"crossref","first-page":"4440","DOI":"10.1182\/blood.V87.10.4440.bloodjournal87104440","article-title":"Sickle erythrocytes adhere to polymorphonuclear neutrophils and activate the neutrophil respiratory burst","volume":"87","author":"Hofstra","year":"1996","journal-title":"Blood"},{"issue":"1","key":"10.1080\/14653240902849788_bib0100","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1182\/blood.V91.1.266","article-title":"Blood polymorphonuclear leukocytes from the majority of sickle cell patients in the crisis phase of the disease show enhanced adhesion to vascular endothelium and increased expression of CD64","volume":"91","author":"Fadlon","year":"1998","journal-title":"Blood"},{"issue":"7","key":"10.1080\/14653240902849788_bib0105","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1046\/j.1537-2995.1998.38798346635.x","article-title":"Expression of neutrophil antigens after 10 days of granulocyte-colony-stimulating factor","volume":"38","author":"Stroncek","year":"1998","journal-title":"Transfusion"},{"issue":"2","key":"10.1080\/14653240902849788_bib0110","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000083451","article-title":"Effect of cytokines and chemokines on sickle neutrophil adhesion to fibronectin","volume":"113","author":"Assis","year":"2005","journal-title":"Acta Haematol"},{"issue":"4","key":"10.1080\/14653240902849788_bib0115","doi-asserted-by":"crossref","first-page":"562","DOI":"10.7326\/0003-4819-74-4-562","article-title":"Reduced red cell glycolysis, 2, 3-diphosphoglycerate and adenosine triphosphate concentration, and increased hemoglobin-oxygen affinity caused by hypophosphatemia","volume":"74","author":"Lichtman","year":"1971","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1080\/14653240902849788_bib0120","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1182\/blood.V63.1.162.162","article-title":"Effect of transfusion therapy on arteriographic abnormalities and on recurrence of stroke in sickle cell disease","volume":"63","author":"Russell","year":"1984","journal-title":"Blood"},{"issue":"6","key":"10.1080\/14653240902849788_bib0125","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0022-3476(95)70204-0","article-title":"Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions","volume":"126","author":"Pegelow","year":"1995","journal-title":"J Pediatrics"},{"issue":"1","key":"10.1080\/14653240902849788_bib0130","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJM199807023390102","article-title":"Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography","volume":"339","author":"Adams","year":"1998","journal-title":"New Engl J Med"},{"issue":"3","key":"10.1080\/14653240902849788_bib0135","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1182\/blood.V99.3.850","article-title":"Mobilization, collection, and processing of peripheral blood stem cells in individuals with sickle cell trait","volume":"99","author":"Kang","year":"2002","journal-title":"Blood"},{"issue":"4","key":"10.1080\/14653240902849788_bib0140","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0022-2836(79)90402-9","article-title":"Gelation of sickle cell hemoglobin in mixtures with normal adult and fetal hemoglobins","volume":"133","author":"Sunshine","year":"1979","journal-title":"J Mol Biol"},{"key":"10.1080\/14653240902849788_bib0145","author":"Abboud","year":"1994"},{"issue":"6","key":"10.1080\/14653240902849788_bib0150","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/bjc.1987.295","article-title":"Phase I\/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer","volume":"56","author":"Bronchud","year":"1987","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1080\/14653240902849788_bib0155","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1172\/JCI113751","article-title":"Phase I study of granulocyte colony-stimulating factor in patients with transitional cell carcinoma of the urothelium","volume":"82","author":"Gabrilove","year":"1988","journal-title":"J Clin Invest"},{"issue":"22","key":"10.1080\/14653240902849788_bib0160","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1056\/NEJM198806023182202","article-title":"Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium","volume":"318","author":"Gabrilove","year":"1988","journal-title":"New Engl J Med"},{"issue":"8587","key":"10.1080\/14653240902849788_bib0165","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0140-6736(88)91475-4","article-title":"Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy","volume":"1","author":"Morstyn","year":"1988","journal-title":"Lancet"},{"issue":"1","key":"10.1080\/14653240902849788_bib0170","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/bjc.1989.234","article-title":"The use of granulocyte colony-stimulating factor to increase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancer","volume":"60","author":"Bronchud","year":"1989","journal-title":"Br J Cancer"},{"issue":"11","key":"10.1080\/14653240902849788_bib0175","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1200\/JCO.1989.7.11.1685","article-title":"Granulocyte colony-stimulating factor stimulates recovery of granulocytes in patients receiving dose-intensive chemotherapy without bone marrow transplantation","volume":"7","author":"Neidhart","year":"1989","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1080\/14653240902849788_bib0180","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1182\/blood.V81.10.2496.2496","article-title":"A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia","volume":"81","author":"Dale","year":"1993","journal-title":"Blood"},{"issue":"12","key":"10.1080\/14653240902849788_bib0185","doi-asserted-by":"crossref","first-page":"4710","DOI":"10.1182\/blood.V90.12.4710","article-title":"A randomized, double-blind, placebo-controlled, phase III study of filgrastim in remission induction and consolidation therapy for adults with de novo acute myeloid leukemia. International Acute Myeloid Leukemia Study Group","volume":"90","author":"Heil","year":"1997","journal-title":"Blood"},{"issue":"21","key":"10.1080\/14653240902849788_bib0190","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1200\/JCO.2006.08.8823","article-title":"Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: a systematic review","volume":"25","author":"Kuderer","year":"2007","journal-title":"J Clin Oncol"},{"issue":"18","key":"10.1080\/14653240902849788_bib0195","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1200\/JCO.2005.05.645","article-title":"Colony-stimulating factors for chemotherapy-induced febrile neutropenia: a meta-analysis of randomized controlled trials","volume":"23","author":"Clark","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1080\/14653240902849788_bib0200","unstructured":"Amgen, I. Neupogen\u00ae Prescribing Information. http:\/\/www.neupogen.com\/pi.html; September, 2007. Accessed 22 September 2008."},{"issue":"3","key":"10.1080\/14653240902849788_bib0205","first-page":"107","article-title":"Beta-thalassaemia major: bone marrow versus peripheral blood stem cell transplantation","volume":"58","author":"Irfan","year":"2008","journal-title":"JPMA"},{"issue":"11","key":"10.1080\/14653240902849788_bib0210","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.bbmt.2007.07.009","article-title":"Comparable long-term survival after bone marrow versus peripheral blood progenitor cell transplantation from matched unrelated donors in children with hematologic malignancies","volume":"13","author":"Meisel","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"10.1080\/14653240902849788_bib0215","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/01.tp.0000275184.41831.6d","article-title":"Similar outcome after unrelated allogeneic peripheral blood stem cell transplantation compared with bone marrow in children and adolescents","volume":"84","author":"Remberger","year":"2007","journal-title":"Transplantation"},{"issue":"13","key":"10.1080\/14653240902849788_bib0220","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.1182\/blood-2006-05-024042","article-title":"Long-term outcome of patients given transplants of mobilized blood or bone marrow: a report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation","volume":"108","author":"Schmitz","year":"2006","journal-title":"Blood"},{"issue":"4","key":"10.1080\/14653240902849788_bib0225","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1182\/blood-2007-03-081596","article-title":"Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia","volume":"110","author":"Schrezenmeier","year":"2007","journal-title":"Blood"},{"issue":"1","key":"10.1080\/14653240902849788_bib0230","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/sj.bmt.1705688","article-title":"Comparison of outcomes after transplantation of peripheral blood stem cells versus bone marrow following an identical nonmyeloablative conditioning regimen","volume":"40","author":"Dey","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1080\/14653240902849788_bib0235","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0301-472X(02)01007-X","article-title":"Long-term marrow reconstitutive ability of autologous grafts in lymphoma patients using peripheral blood mobilized with granulocyte colony-stimulating factor or granulocyte-macrophage colony-stimulating factor compared to bone marrow","volume":"31","author":"Benboubker","year":"2003","journal-title":"Exp Hematol"},{"issue":"6","key":"10.1080\/14653240902849788_bib0240","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1634\/stemcells.22-6-1062","article-title":"Comparison of retroviral transduction efficiency in CD34 + cells derived from bone marrow versus G-CSF-mobilized or G-CSF plus stem cell factor-mobilized peripheral blood in nonhuman primates","volume":"22","author":"Hematti","year":"2004","journal-title":"Stem Cells"},{"issue":"4","key":"10.1080\/14653240902849788_bib0245","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1056\/NEJM199507273330402","article-title":"A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group","volume":"333","author":"Vichinsky","year":"1995","journal-title":"New Engl J Med"},{"issue":"2","key":"10.1080\/14653240902849788_bib0250","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/(SICI)1096-8652(199802)57:2<101::AID-AJH2>3.0.CO;2-#","article-title":"Surgery in patients with hemoglobin SC disease. Preoperative Transfusion in Sickle Cell Disease Study Group","volume":"57","author":"Neumayr","year":"1998","journal-title":"Am J Hematol"},{"issue":"5","key":"10.1080\/14653240902849788_bib0255","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/BF00319890","article-title":"No narcosis for bone marrow harvest in autologous bone marrow transplantation","volume":"49","author":"de Vries","year":"1984","journal-title":"Blut"},{"issue":"11","key":"10.1080\/14653240902849788_bib0260","first-page":"1229","article-title":"A marrow harvest procedure under local anesthesia","volume":"23","author":"Dicke","year":"1995","journal-title":"Exp Hematol"},{"issue":"7","key":"10.1080\/14653240902849788_bib0265","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/sj.bmt.1704418","article-title":"Mobilized blood cells vs bone marrow harvest: experience compared in 171 donors with particular reference to pain and fatigue","volume":"33","author":"Karlsson","year":"2004","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1080\/14653240902849788_bib0270","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1097\/01.qai.0000137371.80695.ef","article-title":"Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection","volume":"37","author":"Hendrix","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"8","key":"10.1080\/14653240902849788_bib0275","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1182\/blood-2003-02-0663","article-title":"Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist","volume":"102","author":"Liles","year":"2003","journal-title":"Blood"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324909702968?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324909702968?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:12:30Z","timestamp":1761430350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324909702968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"references-count":55,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009]]}},"alternative-id":["S1465324909702968"],"URL":"https:\/\/doi.org\/10.1080\/14653240902849788","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2009]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Granulocyte colony-stimulating factor (G-CSF) administration in individuals with sickle cell disease: time for a moratorium?","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1080\/14653240902849788","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}